MegaGen 2026 Q1: Revenue of RMB 349 million, with overseas sales accounting for 68% of total revenue.

Source: MegaGen Implant 2026 Q1 Report

DentalGoodNews｜On May 15, 2026, South Korean Dental Implant company MegaGen Implant released its Q1 2026 financial report. During the reporting period, the company achieved operating revenue of 77.578 billion KRW (approximately RMB 349 million), a year-on-year increase of 10%; Operating Profit was 9.502 billion KRW (approximately RMB 42.759 million); net profit for the period was 2.796 billion KRW (approximately RMB 12.582 million). As of March 31, 2026, MegaGen's total assets stood at 474.365 billion KRW (approximately RMB 2.135 billion).

According to previous reports by DENTALGOODNEWS (Leading Dental Industry Media, DGN), MegaGen faced revenue pressure in 2025, with annual revenue declining by 7.89%. However, through cost control and product structure optimization, the company achieved profit growth.

Source: MegaGen Implant 2026 Q1 Report

In terms of revenue structure, MegaGen's export performance in Q1 was strong, with overseas sales accounting for 68% of total revenue, showing an upward trend. By product category, revenue from self-produced products, including Dental Implants and treatment chairs, reached 59.562 billion KRW, accounting for 76.8% of total revenue; revenue from agency products such as Intraoral Scanning, CT, and other Dental Equipment was 11.901 billion KRW, accounting for 15.3%. Additionally, revenue from A/S services and clinic decoration services amounted to 5.359 billion KRW, accounting for 6.9%; IT revenue related to the dental digital diagnostic software R2 GATE was 358 million KRW, accounting for 0.5%; and other revenue, including education, was 397 million KRW, accounting for 0.5%.

Source: MegaGen Implant 2026 Q1 Report

In terms of R&D and expansion, MegaGen's Q1 R&D investment was 3.425 billion KRW (approximately RMB 15.4125 million), with the R&D-to-revenue ratio increasing from 4.08% in 2025 to 4.41%. The company completed the acquisition of U.S. laser equipment manufacturer BIOLASE in November 2024. The company noted that its MINEC education system has established educational branches in over 30 countries globally, and stated that it has maintained the top position in European exports among South Korean Dental Implant companies for 13 consecutive years.